| 摘要: |
| ［摘要］ 目的 探讨非瓣膜性心房颤动患者规范化使用华法林抗凝治疗的现状，分析影响规范化抗凝治疗的因素，进一步提高规范化抗凝治疗的治疗率。方法 选取2013-01～2015-12收治的510例非瓣膜性房颤患者的临床资料，采用CHADS2评分法筛选出符合要求使用华法林治疗的患者291例进行回顾性分析，评价其规范化抗凝治疗情况。结果 CHADS2评分≥2分符合要求使用华法林的291例患者中，规范化抗凝治疗只有61例（20.9%）。结论 应加强对华法林抗凝治疗效果的认识，提高房颤患者规范化抗凝治疗的控制率和治疗率。 |
| 关键词: 房颤 华法林 规范化抗凝治疗 CHADS2评分 |
| DOI：10.3969/j.issn.1674-3806.2016.11.22 |
| 分类号:R 54 |
| 基金项目: |
|
| The cross-sectional study of warfarin on anticoagulation in patients with nonvalvular atrial fibrillation |
|
ZHAN Ying, ZHOU Han
|
|
Department of Cardiovascular Internal Medicine, the Second Hospital of Nanping City, Fujian 354200, China
|
| Abstract: |
| ［Abstract］ Objective To explore the cross-sectional study of warfarin on anticoagulation in patients with nonvalvular atrial fibrillation and to analyze the influence factors of standardized anticoagulation.Methods The clinical data of 510 patients with nonvalvular atrial fibrillation who were treated in our hospital from January 2013 to December 2015 were screened by CHADS2 score method, in whom the data of 291 cases were retrospectively analyzed.Results Two hundred and ninety-one cases with CHADS2 scores ≥2 points needed the treatment of warfarin, however only 61 cases(20.9%) got the standardized anticoagulant therapy of warfarin.Conclusion The standardized anticoagulant therapy of warfarin should be strengthened in the patient with nonvalvular atrial fibrillation in China. |
| Key words: Atrial fibrillation Warfarin Standardized anticoagulant treatment CHADS2 grading |
